Loading stock data…
CLOV
$4.29+0.37 (+9.44%)
After Hours$4.29+0.00 (+0.00%)· Last close Jun 9
Clover Health Investments, Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Clover Health Investments, Corp. in the Healthcare sector is trading at $4.29. Wall Street consensus targets $3.48 (3 analysts), implying a -18.8% move over the next 12 months. The stock is currently near its 52-week high of $4.44, remaining 63.1% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -18.8% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$4.29
Potential Downside
0%
Whystock Fair Value$4.29
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-16.78%
Volume
Today's trading volume
14.94M
Recent News
3 Growth Stocks With High Insider Ownership And 29% Revenue Growth
Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer unique insights into potential opportunities as insiders may have confidence in their company's future prospects and are often aligned with shareholder interests.
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors?
This healthcare technology company focused on Medicare Advantage plans saw a notable insider sale following a year of strong stock gains.
Why Clover Health (CLOV) Stock Is Up Today
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 9.3% in the afternoon session after Canaccord Genuity raised its price target on the company's shares.
2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Jim Cramer Won't Recommend Mortgage Stocks Because 'I Never Know What They Really Own' — But He Loves Intel's 'Burgeoning Packaging Division'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said that the quarterly results released by Clover Health Investments Corp were "not good." Due to the lackluster results, investors would need to be in "pure spec mode," he added. While the...